tenk.fyi

TScan Therapeutics, Inc.

TCRXNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$10.3M

266.7% YoY

Net Income

-$129.8M

1.8% YoY

EPS

$-1.00

12.3% YoY

Cash

$152.4M

14.7% YoY

FY 2025 · As of 2025-12-31